Interferon α2a therapy for urticarial vasculitis with angioedema apparently following hepatitis a infection

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

A 68-year-old woman with a 5 yr history of chronic recurrert urticarial vasculitis wish angioedema, refractory to conventional treatment including glucocorticosteroids, H1 and H2 blockers, non steroidal antiinflammatory agents, methotrexate, hydroxychloroquine, dapsone, azathioprine, intravenous gamma globulin, and plasma exchange, was successfully treated with interferon α2a. The cause of the urticarial vasculitis remains unknown, although its onset followed a hepatitis A infection. This is the first report of the successful use of interferon α for chronic urticarial vasculitis/angioedema.

Original languageEnglish (US)
Pages (from-to)382-384
Number of pages3
JournalJournal of Rheumatology
Volume23
Issue number2
StatePublished - Mar 4 1996

Keywords

  • Hepatitis A
  • Interferon α
  • Treatment
  • Urticarial vasculitis/angioedema

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Interferon α2a therapy for urticarial vasculitis with angioedema apparently following hepatitis a infection'. Together they form a unique fingerprint.

  • Cite this